Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sartorius CellGenix
Freiburg, Baden-Württemberg, Germanycellgenix.com ↗
- Ownership
- Private
- Employees
- ~70
- Development stage
- Other
01
Overview
CellGenix is a leading global supplier of GMP-grade raw materials (cytokines, growth factors, serum-free media) for cell and gene therapy, with products used extensively in clinical and commercial ATMP manufacturing. CellGenix does not have therapeutics but is critical for enabling CGT clinical trials and commercial products worldwide.
- Modalities
- CytokineGrowth factorRecombinant proteinCell culture mediaCell therapy (enabling)
- Industry
- Chemicals & Materials
02
Partnerships
Ori Biotech (strategic partnership for closed-system manufacturing)Schering AG (historical joint venture)Saint-Gobain Life Sciences (collaboration)ISCT (collaboration)ARM (collaboration)
Beyond the preview
Go deeper on Sartorius CellGenix.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Sartorius CellGenix.